AI assistant
Sending…
MetaVia Inc. — Director's Dealing 2022
Feb 2, 2022
34919_dirs_2022-02-02_2297d0c7-2d99-4e60-99eb-4977cd647da9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2022-01-27
Reporting Person: STRICKLAND D GORDON (Director)
More from MetaVia Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 10
Capital/Financing Update
2026
Apr 7
Regulatory Filings
2026
Apr 3